Potassium Iodide Dosing After Nuclear Detonation
Administer potassium iodide immediately after radioiodine exposure using the following age-based dosing: adults and adolescents ≥18 years or ≥150 lbs receive 130 mg daily; children 3-18 years weighing <150 lbs receive 65 mg daily; children 1 month to 3 years receive 32.5 mg daily; and newborns birth to 1 month receive 16.25 mg daily 1.
Critical Timing Considerations
Potassium iodide must be administered as soon as possible after exposure, ideally within 4-6 hours, when it reduces radioiodine thyroid uptake by approximately 50% 2. The protective effect diminishes rapidly with delayed administration:
- 90% effectiveness at 1 day
- 80% effectiveness at 2 days
- 50% effectiveness at 3 days
- Only 50% protection at 6 hours post-exposure, 25% at 12 hours, and merely 6% at 24 hours 3
Age-Specific Dosing Protocol
Based on FDA labeling 1:
- Adults >18 years: 130 mg (2 mL oral solution) daily
- Adolescents 12-18 years weighing ≥150 lbs: 130 mg (2 mL) daily
- Adolescents 12-18 years weighing <150 lbs: 65 mg (1 mL) daily
- Children 3-12 years: 65 mg (1 mL) daily
- Children 1 month to 3 years: 32.5 mg (0.5 mL) daily
- Newborns birth to 1 month: 16.25 mg (0.25 mL) daily
Duration of Treatment
Continue daily dosing every 24 hours as directed by public officials until the risk of radioiodine exposure ceases 1. For prolonged or repeated exposure scenarios, daily administration of 50 mg iodide maintains thyroid blockade above 90% 4, 3. Never exceed one dose per 24 hours—additional doses do not improve protection and increase toxicity risk 1.
Special Populations
Pregnant Women
Pregnant women in the second and third trimesters must receive potassium iodide for both near-field and far-field exposures to protect both maternal and fetal thyroid glands 2. The fetal thyroid begins functioning around 12 weeks gestation and is more iodine-avid than the adult thyroid, making protection critical 2. First-trimester pregnant women require protection primarily in near-field exposures 2.
Infants and Children
Children, adolescents, and fetuses have the highest priority for prophylaxis due to their radiosensitive thyroid glands and elevated risk of radiation-induced thyroid cancer, which may be more aggressive than spontaneous thyroid cancer 2, 5. Despite the risk of hypothyroidism (especially in newborns), the cancer prevention benefit outweighs this risk 4.
Critical Caveats and Contraindications
When NOT to Use Potassium Iodide
Do not administer potassium iodide for "dirty bomb" (radiologic dispersal device) exposures 2. These devices have an 8.5-day half-life making radioiodine incorporation extremely unlikely, while potassium iodide carries risk of life-threatening anaphylaxis without benefit 2.
Allergy Precautions
Exercise extreme caution in patients with personal history of iodine allergy—severe allergic reactions including life-threatening anaphylaxis have been reported 2.
Elderly Considerations
For elderly patients, the benefits of potassium iodide may be lower than the risk of iodine-induced hyperthyroidism 4. However, standard dosing should still be administered when radioiodine exposure is confirmed.
Mechanism and Rationale
Potassium iodide works by saturating the thyroid gland with non-radioactive iodine, blocking uptake of radioactive iodine-131 and iodine-125 2. The thyroid concentrates iodine with great efficiency, making it vulnerable to localized radioactivity that can cause thyroid cancer as a delayed consequence 2. Primary exposure routes include inhalation in near-field areas and ingestion of contaminated food/milk in far-field areas 2.
Potassium iodide is NOT a generic anti-radiation drug—it only protects the thyroid from radioiodine and provides no protection against other radiation types 2.